Fenwick represented Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry, announced the...
Royalty Pharma’s Interest Acquisition in Amgen’s Olpasiran
Zibuyu Group Limited’s HK$197.7 Million IPO
Harneys acted as Cayman Islands counsel to Zibuyu Group Limited on the listing. Tian Yuan Law Firm LLP provided Hong Kong legal advice to Zibuyu and...